BL-918 activates PINK1/Parkin signaling pathway to ameliorate the progression of Parkinson’s disease
Yi Wang(King Center), Conggang Zhang(Center for Life Sciences)
Cited by 16
Related Papers
Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1–Parkin pathway and modulate cellular drug response
|Journal of Biological Chemistry|2017|104